Form 4: Astera Labs President Sanjay Gajendra Sells Shares
Statement of Changes in Beneficial Ownership
Astera Labs President and COO Sanjay Gajendra executed a series of stock sales totaling over 180,000 shares via a 10b5-1 plan.
Summary
- President and COO Sanjay Gajendra sold a total of 180,558 shares of Astera Labs (ALAB) common stock on May 7, 2026.
- The transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025.
- Shares were sold in multiple tranches at weighted average prices ranging from $193.01 to $213.49 per share.
- The shares were held indirectly through two estate planning trusts.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; while insider selling is often viewed with caution, the use of a pre-planned 10b5-1 arrangement suggests routine financial management rather than a reaction to negative internal information.
Positives
- The sales were conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell stock without triggering insider trading concerns.
Negatives
- Significant reduction in indirect beneficial ownership by a key executive (President and COO).
Risks
- Large-scale insider selling can sometimes be perceived negatively by the market as a signal of potential valuation peaks.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing, as it is a standard disclosure of insider transaction activity.
Industry Context
StockSavvy.ai notes that executive selling via 10b5-1 plans is common practice for liquidity and estate planning, particularly following periods of strong stock performance in the semiconductor and data infrastructure sectors.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate officers to manage equity holdings while maintaining compliance with SEC regulations.
- The scale of the sale is consistent with typical executive diversification strategies for high-growth technology companies.
Stakeholder Impact
- Shareholders should note the reduction in the President's indirect holdings, though the pre-planned nature of the sale mitigates concerns regarding insider sentiment.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 2025-12-02 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-05-07 | Date of the reported stock transactions. |
| 2026-05-11 | Date the Form 4 was signed and filed. |
Keywords
Astera Labs, ALAB, Insider Trading, Form 4, Sanjay Gajendra, Stock Sale, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.